title: [Corticosteroids and diabetes mellitus].
abstract: During corticosteroid prescriptions, diabetes mellitus may be completely deregulated or may be revealed as such. Predisposition to diabetes mellitus could be because of latent β Langerhans cell deregulation or because enhancement of tissue sensitivity by glucocorticosteroids. However, epidemiologic data concerning predisposing factors and frequency of cortico-induced diabetes are not well known. Detection, treatment and prevention are the same as for type II diabetes. Glycemia should be monitored throughout long-term treatments.
authors.affiliation: Université Paris-Descartes, AP-HP, Hôtel-Dieu, service de médecine interne, 75004 Paris, France.
authors.forename: Laura
authors.initials: L
authors.lastname: Gagliardi
authors.forename: Claire
authors.initials: C
authors.lastname: Le Jeunne
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D003907:Dexamethasone / Q000009:adverse effects / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000139:chemically induced; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008134:Long-Term Care
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D001786:Blood Glucose; D007166:Immunosuppressive Agents; D007328:Insulin; D003907:Dexamethasone